Matson Inc <MATX.N>: Stephens raises target price to $260 from $240
MATX•Related News
Elite Pharma launches generic Requip XL ropinirole extended-release tablets in US
ELTP•
Pfizer Q2 results beat; raises 2026 revenue outlook
PFE•
Germany's BioNTech Q2 revenue drops 60% on lower COVID-19 vaccine demand
BNTX•
Marathon Petroleum climbs as quarterly profit beat estimates
MPC•
Wheels Up Q2 net loss widens on higher interest, lease costs
UP•